Comparison of Russian regions by standardized mortality rates from all causes and circulatory system diseases in 2006-2016

Drapkina, О. М.; Samorodskaya, I. V.; Starinskaya, M. A.; Boytsov, S. А.

doi:10.17116/profmed20182144

Cited by 21 publications

(12 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В последнее десятилетие во многих странах мира стало уделяться большое внимание mHealth [5,6], дающему возможность реализации новых форм оказания медицинских услуг населению -медицина шаговой доступности, в том числе посредством создания офлайн-клиник и осуществлению дистанционных обучающих программ, которые позволят повысить осведомлённость населения о здоровье и его детерминантах, что положительно скажется на сокращении показателей заболеваемости и преждевременной смертности [2]. Среди 3 686 профилактически проконсультированных на оборудованной медицинской площадке торговых центров и фельдшерско-акушерских пунктов мужчин было в два раза меньше, чем женщин (соответственно, 1 206 (33%) и 2 480 (67%) человек).…”

Section: результаты и обсуждениеunclassified

“…Несмотря на положительную динамику снижения смертности в России от болезней системы кровообращения (БСК) [1], она значительно превышает показатели европейских стран, что требует внедрения эффективных программ профилактики и лечения сердечно-сосудистых заболеваний [2,3]. Это в значительной мере относится и к Тверской области, которая на протяжении многих лет занимает позиции аутсайдера как по показателям общей смертности, так и смертности от БСК.…”

Section: Introductionunclassified

See 1 more Smart Citation

Mobile H Ealth Technology: Organizational, Medical and Pharmacoepidemiological Approaches for CSD Prevention in Pre-Primary Care

Kirilenko

Красненков

Соловьёва

et al. 2019

Arhivʺ vnutrennej mediciny

View full text Add to dashboard Cite

Objective: to evaluate the innovative organizational, medical and pharmacoepidemiological approaches for the prevention of circulatory system diseases in pre-primary care using mobile health technologies.Materials and methods: 3,694 people went through preventive consultation (questionnaires, anthropometry, body fat and blood pressure evaluation, electrocardiography, glucose and blood cholesterol) at equipped medical sites in shopping centers and rural health posts.Results. Among the surveyed, there were both healthy people and patients cardiovascular diseases and diabetes mellitus. Behavioral (insufficient consumption of fruits and vegetables, adding more salt without trying food, physical inactivity, smoking and alcohol abuse) and nutritional (obesity, hypertension, hypercholesterolemia and glycaemia) risk factors of chronic noncommunicable diseases were detected that contribute to high mortality from circulatory system diseases in the Tver region. This is associated with low adherence to drug therapy and its lack of efficacy in patients with hypertension, ischemic heart disease and cerebrovascular diseases.Conclusion: to assess the effectiveness of CSD prevention in pre-primary care, it is possible to use mobile medical sites in shopping centers and rural health posts.

show abstract

Section: результаты и обсуждениеunclassified

Section: Introductionunclassified

Mobile H Ealth Technology: Organizational, Medical and Pharmacoepidemiological Approaches for CSD Prevention in Pre-Primary Care

Kirilenko

Красненков

Соловьёва

et al. 2019

Arhivʺ vnutrennej mediciny

View full text Add to dashboard Cite

show abstract

“…Несмотря на то, что в Российской Федерации в настоящее время наблюдается снижение смертности от сердечно-сосудистых заболеваний [1], в структуре причин смертности населения ишемическая болезнь сердца (ИБС) занимает лидирующее положение [2]. Острые формы ИБС -инфаркт миокарда (ИМ) и нестабильная стенокардия (НС) являются ведущей причиной смертности этой группы пациентов [3].…”

Section: Introductionunclassified

Evaluation of Procalcitonin Levels in Patients with Various Forms of Acute Coronary Syndrome, Depending on the Presence of Adverse Hospital Outcomes

Драпкина¹,

Zakharova²

2021

Racionalʹnaâ farmakoterapiâ v kardiologii

Self Cite

View full text Add to dashboard Cite

Aim. to study the levels of procalcitonin in patients with various forms of acute coronary syndrome (ACS), depending on the presence of adverse hospital outcomes.Materials and Methods. The study included 222 patients admitted to the emergency cardiology department with a diagnosis of ACS in the period from March 2014. until January 2017. Of these, 106 (47.7 %) patients were diagnosed with unstable angina (NS) and 116 (52.3%) with myocardial infarction (MI). Non ST segment elevation MI (NSTEMI) was diagnosed in 47 (40.5%) patients with MI, and ST elevation MI (STEMI) – in 69 (59.5%) patients with MI. After the assessment of the patient's compliance with the criteria for inclusion/exclusion in the study, the procedure for signing the patient's informed consent form was carried out. The protocol of the study was approved by the local Ethics committee of the M. E. Zhadkevich State Clinical Hospital. In each study subgroup, the presence of adverse outcomes during the current hospitalization was assessed: cardiovascular death, nonfatal MI, nonfatal acute cerebrovascular accident, acute heart failure, as well as a combined endpoint, including all of the listed adverse outcomes. All patients, in addition to routine laboratory methods of investigation, were examined for the level of procalcitonin at admission to the hospital, on 2-3 and 4-5 days.Results. Patients with MI compared to patients with NS were characterized by a large number of registered endpoints in general (24.1% vs. 6.6%, p<0.001), while in the group of patients with MI, cardiovascular death was more often recorded (10.3% vs. 0.9%, p<0.001) and acute heart failure (12.9% vs. 5.6%, p=0.009). Patients with MI, in particular with STEMI, who had adverse hospital outcomes, were characterized by statistically significantly higher levels of procalcitonin compared to patients without adverse hospital outcomes. Patients with STEMI showed significantly higher levels of procalcitonin at all stages of the disease, and patients with MI-only at 2-3 and 4-5 days. There were no statistically significant differences in the level of procalcitonin at all stages of the disease in patients with NSTEMI and with unstable angina, depending on the hospital outcomes.Conclusion. Elevated procalcitonin levels in patients with MI, in particular with STEMI, are associated with adverse hospital outcomes; for other forms of ACS, no statistically significant differences were observed with different hospital outcomes.

show abstract

“…В России, несмотря на достижение определенных положительных результатов [2], смертность от болезней системы кровообращения остается одной из самых высоких в мире, чем обусловлен суммарный экономический ущерб около 2,7 трлн руб. в год (3,2% от ВВП) [3].…”

Section: Introductionunclassified

Use of the Dominant Component Analysis for Improvement of Preventive Measures in Patients with Cardiovascular Risks

Kovrigina¹,

Болотова²,

Kontsevaya³

2021

View full text Add to dashboard Cite

Study Objective: To improve efficiency of cardiovascular disease (CVD) prevention in patients with health category IIIa in Krasnodar Territorial Outpatient Clinic using a factorial analysis (dominant component analysis) of stage 1 health assessment results for 2015 and 2018. Materials and Methods. The study includes subjects who underwent stage 1 health assessment: 2015 — 2,461 people, 2018 — 2,772 people. Patients with health category IIIa were assessed for modifiable risk factors (RF) of CVDs using the dominant component analysis. Study Results. In 2015, health category IIIа was assigned to 29.9% of patients; female patients accounted for 68.5% (median age: 62 years), males accounted for 31.5% (median age: 60 years). In 2018, health category IIIа was recorded for 41.5% of patients; female patients accounted for 64.3% (median age: 63 years), males accounted for 35.7% (median age: 62 years). Factorial analysis demonstrated that male patients have the following composition of modifiable CVD RFs: factor 1 — improper diet (ID) and physical inactivity (PIA); factor 2 — hypercholesterolemia (HCS), tobacco smoking and alcohol abuse (TSAA); factor 3 — arterial hypertension (AH) and ID; factor 4 — AH. Women demonstrated different compositions of CVD RFs: factor 1 — ID and PIA; factor 2 — AH and HCS; factor 3 — BMI > 25 kg/m2 and hyperglycemia; factor 4 — TSAA. Conclusion. Gender differences together with modifiable CVD RFs in patients with risk category IIIa revealed with the help of the dominant component analysis allow correcting RFs taking into account combinations, most contributing to unfavourable cardiovascular events. Keywords: health assessment, risk factor, circulatory diseases, prevention, outpatient clinic, factorial analysis.

show abstract

Comparison of Russian regions by standardized mortality rates from all causes and circulatory system diseases in 2006-2016

Cited by 21 publications

References 10 publications

Mobile H Ealth Technology: Organizational, Medical and Pharmacoepidemiological Approaches for CSD Prevention in Pre-Primary Care

Mobile H Ealth Technology: Organizational, Medical and Pharmacoepidemiological Approaches for CSD Prevention in Pre-Primary Care

Evaluation of Procalcitonin Levels in Patients with Various Forms of Acute Coronary Syndrome, Depending on the Presence of Adverse Hospital Outcomes

Use of the Dominant Component Analysis for Improvement of Preventive Measures in Patients with Cardiovascular Risks

Contact Info

Product

Resources

About